Ihalapathirana, A.; Lavikainen, P.; Siirtola, P.; Tamminen, S.; Chandra, G.; Laatikainen, T.; Martikainen, J.; Röning, J.
Beyond Glycemic Control: Precision Medicine in Type 2 Diabetes Using Multi-Output Explainable Artificial Intelligence for Personalized SGLT2 and DPP-4 Therapy Selection. AI 2026, 7, 183.
https://doi.org/10.3390/ai7060183
AMA Style
Ihalapathirana A, Lavikainen P, Siirtola P, Tamminen S, Chandra G, Laatikainen T, Martikainen J, Röning J.
Beyond Glycemic Control: Precision Medicine in Type 2 Diabetes Using Multi-Output Explainable Artificial Intelligence for Personalized SGLT2 and DPP-4 Therapy Selection. AI. 2026; 7(6):183.
https://doi.org/10.3390/ai7060183
Chicago/Turabian Style
Ihalapathirana, Anusha, Piia Lavikainen, Pekka Siirtola, Satu Tamminen, Gunjan Chandra, Tiina Laatikainen, Janne Martikainen, and Juha Röning.
2026. "Beyond Glycemic Control: Precision Medicine in Type 2 Diabetes Using Multi-Output Explainable Artificial Intelligence for Personalized SGLT2 and DPP-4 Therapy Selection" AI 7, no. 6: 183.
https://doi.org/10.3390/ai7060183
APA Style
Ihalapathirana, A., Lavikainen, P., Siirtola, P., Tamminen, S., Chandra, G., Laatikainen, T., Martikainen, J., & Röning, J.
(2026). Beyond Glycemic Control: Precision Medicine in Type 2 Diabetes Using Multi-Output Explainable Artificial Intelligence for Personalized SGLT2 and DPP-4 Therapy Selection. AI, 7(6), 183.
https://doi.org/10.3390/ai7060183
